{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:30:40Z","timestamp":1793115040756,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To assess whether pharmacist prescription of combined hormonal contraception is associated with 12-month contraceptive continuation rates or breaks in contraceptive coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of all short-acting, hormonal contraceptive users (pill, patch, ring, injectable) in Oregon's All Payer All Claims database from January 1, 2016, to December 31, 2018. We captured contraceptive use using diagnosis and National Drug Classification codes. We used logistic regression to measure the association between prescription by a pharmacist and 12-month contraceptive continuation rates and breaks in contraceptive coverage. Model covariates included age, rurality, and payer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Our study sample consisted of 172,325 contraceptive users, of whom 1,512 (0.9%) received their prescriptions from a pharmacist. Pharmacists were significantly more likely than clinicians to prescribe to women between the ages of 25 and 34 years (50.5% vs 36.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05), in urban settings (88.4% vs 81.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05), and with commercial insurance (89.2% vs 59.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.05). We found that the rate of 12 months contraceptive continuation was higher among the population receiving a pharmacist prescription (34.3% vs 21.0%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.01). In an adjusted model, the odds of contraceptive continuation at 12 months were 61.0% higher for individuals with any pharmacist prescription (adjusted odds ratio [aOR] 1.61, 95% CI 1.44\u20131.79) compared with those with clinician prescriptions. Over 6 months, most contraceptive users in both groups experienced a\n                      <jats:italic toggle=\"yes\">break in coverage<\/jats:italic>\n                      , defined as a gap of 1\u201329 days between prescriptions (61.6% vs 61.9%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.89). Breaks in contraceptive use were not significantly associated with prescriber type (aOR 1.03, 95% CI 0.90\u20131.18).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Compared with clinician prescriptions, pharmacist prescription of contraception is associated with increased odds of 12-month contraceptive continuation rates. However, the frequency of breaks in contraceptive coverage was similar among pharmacist and clinic-based prescribers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING SOURCE:<\/jats:title>\n                    <jats:p>Arnold Ventures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004752","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T14:03:54Z","timestamp":1652709834000},"page":"781-787","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Association of Pharmacist Prescription of Contraception With Breaks in Coverage"],"prefix":"10.1097","volume":"139","author":[{"given":"Maria I.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynna","family":"Manibusan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menolly","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. John","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"R2-20260916","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008-2011","volume":"374","author":"Finer","year":"2016","journal-title":"N Engl J Med"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/AOG.0000000000003473","article-title":"Over-the-counter access to hormonal contraception. ACOG Committee Opinion No. 788. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R6-20260916","first-page":"968","article-title":"The potential impact of over-the-counter access to oral contraceptives to reduce unintended pregnancy","volume":"92","author":"Grossman","year":"2015","journal-title":"Am Fam Physician"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.contraception.2010.08.003","article-title":"Understanding prescription adherence: pharmacy claims data from the Contraceptive CHOICE Project","volume":"83","author":"Pittman","year":"2011","journal-title":"Contraception"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2013.03.024","article-title":"Adherence to hormonal contraception among women veterans: differences by race\/ethnicity and contraceptive supply","volume":"209","author":"Borrero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1363\/3904807","article-title":"U.S. women's one-year contraceptive use patterns, 2004","volume":"39","author":"Frost","year":"2007","journal-title":"Perspect Sex Reprod Health"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/AOG.0000000000003286","article-title":"Pharmacist provision of hormonal contraception in the Oregon Medicaid population","volume":"133","author":"Anderson","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/AOG.0000000000003265","article-title":"Association of pharmacist prescription of hormonal contraception with unintended pregnancies and Medicaid costs","volume":"133","author":"Rodriguez","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"e205252","DOI":"10.1001\/jamanetworkopen.2020.5252","article-title":"Association of pharmacist prescription with dispensed duration of hormonal contraception","volume":"3","author":"Rodriguez","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.contraception.2020.05.016","article-title":"Reasons for and experience in obtaining pharmacist prescribed contraception","volume":"102","author":"Rodriguez","year":"2020","journal-title":"Contraception"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.contraception.2008.11.013","article-title":"One versus multiple packs for women starting oral contraceptive pills: a comparison of two distribution regimens","volume":"79","author":"Chin-Quee","year":"2009","journal-title":"Contraception"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/AOG.0b013e3182056309","article-title":"Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies","volume":"117","author":"Foster","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.AOG.0000239122.98508.39","article-title":"Number of oral contraceptive pill packages dispensed, method continuation, and costs","volume":"108","author":"Foster","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/AOG.0000000000001474","article-title":"Prescription of hormonal contraception by pharmacists in Oregon: implementation of House Bill 2879","volume":"128","author":"Rodriguez","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/1060028016653608","article-title":"The continuum of pharmacist prescriptive authority","volume":"50","author":"Adams","year":"2016","journal-title":"Ann Pharmacother"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"647.e1","DOI":"10.1016\/j.ajog.2021.06.089","article-title":"Association of pharmacist prescription and 12-month contraceptive continuation rates","volume":"225","author":"Rodriguez","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"e2012540","DOI":"10.1001\/jamanetworkopen.2020.12540","article-title":"Association of implementing an incentive metric in the Oregon Medicaid program with effective contraceptive use","volume":"3","author":"Rodriguez","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study","volume":"172","author":"St\u00fcrmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.contraception.2021.06.004","article-title":"Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist","volume":"104","author":"Rodriguez","year":"2021","journal-title":"Contraception"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2006.07.006","article-title":"Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception","volume":"74","author":"Landau","year":"2006","journal-title":"Contraception"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/AOG.0b013e31818345f0","article-title":"Accuracy of self-screening for contraindications to combined oral contraceptive use","volume":"112","author":"Grossman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31820b0244","article-title":"Contraindications to combined oral contraceptives among over-the-counter compared with prescription users","volume":"117","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2016.03.047","article-title":"Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use","volume":"215","author":"Lauring","year":"2016","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:51Z","timestamp":1789556631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004752","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"2021-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}